Mr JS, 23yo man Initially presented with haematochezia, abdominal pain and IBS-like Sx Family Hx of father with bowel cancer, age 40 Diagnosis of Lynch.

Slides:



Advertisements
Similar presentations
This short questionnaire will help to determine whether there may be a gene in your family connected to an increased risk of the development of bowel.
Advertisements

Surveillance/ Screening Colonoscopy for Colorectal Cancer
Introduction to Cancer Genetics
Lynch Syndrome and Colorectal Cancer Steven G. Proshan, M.D. Annapolis Colon and Rectal Surgeons Anne Arundel Medical Center November 8,
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
Gynecologic Cancers Presented by: Michael Goodheart, MD Assistant Professor Gynecologic Oncology The University of Iowa Hospitals & Clinics Understanding,
COLORECTAL CARCINOMA Bernard M. Jaffe, MD Professor of Surgery Emeritus.
A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
COLORECTAL BLEEDING: a multidisciplinary approach Torino, 31 marzo-1 aprile 2006 GENETIC EVALUATION Schena M, Angelini F, Bertetto O. Department of Medical.
Colorectal Cancer Ramon Garza III, M.D.. Colorectal CA DNA Sequencing Mismatch Repair Genes Genomics Role of PCR and FISH in Colon CA.
Mismatch Repair deficient CRC: implications for clinical practice Yoland Antill Medical Oncologist Cancer Genetics.
Colon Cancer Basic Science 9/21/05. Colon and rectal neoplasms are characterized by: Consist of the third most common site of new cancer cases and deaths.
Genetics and Ovarian Cancer Jeanne M. Schilder, M.D. Associate Professor, Gynecologic Oncology Indiana University Medical Center September 19, 2012.
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
Comprehensive IHC Screening for Lynch Syndrome: What You Need to Know Andrea Lewis, MS, CGC January 14, 2010.
Is Your Patient At Risk of Having Lynch Syndrome? David Strassler, MD Martin’s Point Health Care Biddeford, Maine
Pancreas Cancer Nimisha K. Parekh, MD, MPH
Morning Report May 20, 2009 Bridger Clarke  Born in Lawrence, Massachusetts, on 4 January  Dropped out of high school at the age of fourteen.
SURVIVORS TEACHING STUDENTS: SAVING WOMEN’S LIVES®
Cancer Genetics for Primary Care Sara Levene Registered Genetic Counsellor.
Cancer Dr. Raid Jastania. Cancer In the US: 1.3 million new cancer cases in 2002 >500,000 death of cancer Increase cancer death in men due to lung cancer.
Colon cancer By: Brittany Mares.
By: Ashleen Atchue and Mario Tovar
Personalised Medicine in Colorectal Cancer? Mr Arfon G M T Powell MB ChB MSc MRCSEd Clinical Research Fellow in Surgery.
OVARIAN CANCER Talking point: Genetics of ovarian cancer.
Ovarian cancer….. in 15 minutes
Colorectal cancer Khayal AlKhayal MD,FRCSC
West Midlands Regional Genetics Laboratory
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Immunohistochemistry (IHC) for Microsatellite Instability Fact Sheet Frequently Asked Questions What is Lynch Syndrome? Lynch syndrome is a hereditary.
Genetics & Colorectal Cancer
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
General Medicine Subspecialty Conference Colon Cancer Screening General Medicine Subspecialty Conference Colon Cancer Screening Selim Krim, MD Assistant.
Genetics of Colorectal Cancer
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
Colorectal carcinoma Dr.Mohammadzadeh.
Screening and Detection in Cancer Survivors
Colorectal cancer Khayal AlKhayal MD,FRCSC Assistant professor of Surgery Consultant Colorectal surgeon 9/11/2015Shwartz.
Resection For Lung Metastases M62 Coloproctology Course.
Chapter 28 Lung Cancer. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives  Describe the epidemiology of.
MRS PC, 63YO WOMAN  Initially presented with chronic RIF pain  Found to have cholelithiasis, underwent a laparoscopic cholecystectomy  On the laparoscopy,
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Endometrial Carcinoma
COLON CANCER A MAJOR ISSUE IN ALASKA. A common malignancy 200,000 cases in the U. S. in ,000 cases in the U. S. in 2008 Greater than 50 new cases.
Tumour Analysis-Lynch Syndrome Dr Alan Donaldson Consultant in Clinical Genetics Bristol.
Neoplasms of the bladder
סרטן מעי גס אבחון מוקדם מניעה טיפול מונע ד"ר הוברט אילה מנהלת המרכז לגידולים במערכת העיכול מכון שרת הדסה עין כרם.
A 58 years old man presents with melena. What would you ask him?
Cancer Prevention Eyad Alsaeed, MD,FRCPC Consultant Radiation Oncology PSHOC KFMC.
Evaluation Of Colonic Polyps Kathia E. Rosado Orozco MD GI and Liver Pathologist Hato Rey Pathology Associates.
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
Recent and evolving trends in breast and colon cancer by Jeff Kolbasnik.
Definition Signs & symptoms Treatment Root of the disease.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
Do you have 3 or more affected relatives? (2 or less)
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
Case. Kreem is 53 year old man who is quite healthy with no previous illness. He has noticed changes in his bowel habits for the last few months, with.
Lynch Syndrome or Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
Screening for Ovarian Cancer
Cancer Can Not Comfort But Your Family Can
Hereditary Gastrointestinal Cancers
Michael Lin, Jenn Hian Koo, David Abi–Hanna 
Surveillance of Dysplasia in Inflammatory Bowel Disease: The Gastroenterologist- Pathologist Partnership  David T. Rubin, Jerrold R. Turner  Clinical Gastroenterology.
Polyps of the Colon and Rectum
Lynch syndrome (LS) Hereditary Non-polyposis Colorectal Cancer (HNPCC)
Colonic polyps and tumors
Presentation transcript:

Mr JS, 23yo man Initially presented with haematochezia, abdominal pain and IBS-like Sx Family Hx of father with bowel cancer, age 40 Diagnosis of Lynch syndrome – Unclear how or when this diagnosis was made Otherwise well, ex-smoker (3 pack years) On colonoscopy investigating haematochezia, multiple polyps were found and excised

Malignant sigmoid polyp (sessile serrated adenoma) Subsequent staging investigations confirmed T1N0M0 disease

Synchronous tubular adenoma with low grade dysplasia

Treatment of the Colon Ca Diagnosed with Lynch syndrome – Unclear how or when this diagnosis was made Underwent total colectomy for definitive treatment of colon cancer and prophylaxis – No neoadjuvant or adjuvant therapy at this time Complications of this treatment: – Urinary symptoms, incl. pis-en-deux, trouble initiating and urinary retention – Short bowel syndrome

Follow up CT Chest at 1 year follow up showed: – 14mm LLL lesion – L) hilar and aortopulmonary lympadenopathy These areas were shown to be intensely avid on FDG-PET CT Abdo at this time showed (non-avid): – Small calcified opacities – Bulky L) adrenal, nil definite mass – 2x small mesorectal nodes

Biopsy EBUS and biopsy was undertaken Results: – Poorly differentiated adenocarcinoma – Signet ring morphology – TTF1 and CK7 +ve – CK20 and CDX2 –ve – This IHC is consistent with primary lung adenocarcinoma

Signet ring cells

Initial treatment of the Lung Ca Not resectable RT to the chest Complicated by severe radiation oesophagitis – Requiring 2/52 admission for IV fluid therapy Coupled with sensitising CTx regime – Cisplatin/Etoposide

Progress Repeat PET following radiochemotherapy – Hilar nodal disease shrunk, although remained avid – New avid areas L5 transverse process L) adrenal 2 nd line CTx with Carboplatin/Pemetrexed

Chemotherapy SEs He is troubled by fatigue and severe stabbing headaches Other SEs he has experienced include: – Nausea – Hiccoughs – Hot flushes – Sleep disturbance – Nosebleeds

Social Hx Lives at home with parents and older sister Has a girlfriend Works as a partner manager, previously full time – Now works from home when able Father has not been formally diagnosed with Lynch syndrome Others in the family are considering screening They are all extremely worried for him

Social Hx (cont.) Otherwise he is active, getting out of the house on days when he feels well enough ECOG 1, symptoms limiting him only sometimes Sees friends often, goes to parties, etc.

Lynch syndrome Hereditary cancer syndrome, mediated by mutation to one of several DNA mismatch repair genes – Examples include MLH1, MSH2, MSH6 and PMS2 Phenotypically expressed as increased risk of several types of cancer (~30-50% risk), including: – Bowel – Endometrial – Ovarian – Renal pelvis TCC No proven association with lung cancer

Screening for hereditary Ca syndrome Genetic screening based on probability of gene being found – Funded test if probability >10% Bowel cancer at a young age alone is not necessarily enough to score a test FHx feature typical of a hereditary syndrome: – Multiple cancers in the family – Young age at onset of cancer – Multiple cancers in the same individual In Lynch, tumour typing may involve tests for MMR and MSI, which detects additional cases

Bowel Ca screening Population Average risk individuals: FOBT funded at 50, 55, 60 and 65 years Recent budget included provisions for 2 yearly FOBT for those aged 50-74, to be phased in by 2020 Moderate risk individuals: 5 yearly colonoscopy from age 50 or 10 years before earliest diagnosis in the family High risk individuals: Consider referral to a family cancer clinic Lynch syndrome Colonoscopy every 1-2 years from 25 years, or 5 years from earliest diagnosis in the family - Cancer Council guidelines (2008) Screening for other cancers associated with Lynch may be indicated, i.e. haematuria/urine cytology

Cancer prophylaxis in Lynch Aspirin 600mg d (CAPP2 trial) – Highly significant decreased risk of cancer vs. potato starch – No significant difference in adverse events while on aspirin Surgical prophylaxis – Total colectomy – Hysterectomy + salpingoophrectomy